NAD
This article was originally published in The Rose Sheet
Executive Summary
The National Advertising Division of the Council of Better Business Bureaus has referred Freeman Beauty Labs to the Federal Trade Commission after the company failed to respond to the watchdog group's inquiry regarding claims for its Renewance Anti-Aging Chemical Peel, NAD reports Aug. 31. The group had requested substantiation for claims the product "offers a Pomegranate AntiOx Peptide Complex [that] restores skin's water, plumping fine lines and wrinkles," "protects against water loss and dehydration," and "delivers 92% wrinkle reduction, 88% tighter, toned skin, 92% smoother younger looking skin and 88% more radiant skin"...
You may also be interested in...
Anti-Aging Formula’s Ad Claims Unsupported By Studies – NAD
Freeman Beauty Labs will discontinue unsupported advertising claims for Renewance Anti-Aging Chemical Peel following a review by the National Advertising Division of the Council of Better Business Bureaus, which was featured in a recent Case Reports
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.